SC
NTLA icon

Scholtz & Company’s Intellia Therapeutics NTLA Stock Holding History

Scholtz & Company’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,185
Closed -$293K – 68
2021
Q3 		$293K Sell
2,185
-760
-26% -$102K 0.1% 60
2021
Q2 		$477K Buy
+2,945
New +$477K 0.16% 57